4//SEC Filing
Verstraete Stephany 4
Accession 0001477449-24-000046
CIK 0001477449other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:10 PM ET
Size
29.3 KB
Accession
0001477449-24-000046
Insider Transaction Report
Form 4
Verstraete Stephany
Chief Marketing Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-01+4,437→ 47,554 total - Exercise/Conversion
Common Stock
2024-03-01+437→ 47,991 total - Exercise/Conversion
Common Stock
2024-03-01+867→ 48,858 total - Exercise/Conversion
Common Stock
2024-03-01+1,404→ 50,262 total - Exercise/Conversion
Common Stock
2024-03-01+13,021→ 63,283 total - Exercise/Conversion
Common Stock
2024-03-01+1,148→ 64,431 total - Sale
Common Stock
2024-03-04$14.52/sh−7,945$115,330→ 56,486 total - Award
Performance Stock Units
2024-03-01+13,313→ 13,313 total→ Common Stock (13,313 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−4,437→ 8,876 total→ Common Stock (4,437 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−437→ 0 total→ Common Stock (437 underlying) - Exercise/Conversion
Performance Stock Units
2024-03-01−867→ 0 total→ Common Stock (867 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−1,404→ 5,616 total→ Common Stock (1,404 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−13,021→ 26,042 total→ Common Stock (13,021 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-01−1,148→ 0 total→ Common Stock (1,148 underlying)
Footnotes (12)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F10]On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F11]On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F12]On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- [F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
- [F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F7]On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F8]On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
- [F9]On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
Documents
Issuer
Teladoc Health, Inc.
CIK 0001477449
Entity typeother
Related Parties
1- filerCIK 0001726419
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:10 PM ET
- Size
- 29.3 KB